glp-1 medications for weight loss Agonists: A Comprehensive Overview Comparing GLP‑1 Drugs With Other

During the phase 3 trial of tirzepatide, 6.6% of patients discontinued the medication due to side effects [114]

The strengths of the DTI analysis include its large, nationally representative sample size, longitudinal monitoring, a testing population that is generally reflective of the U.S

References PubMed: Physiology of GLP-1 DrugBank: GLP-1 biological role NCBI Bookshelf: Incretin hormones overview StatPearls: GLP-1 physiology [Textbook: Goodman & Gilmans The Pharmacological Basis of Therapeutics, 13th ed.]

These injections contain specialized compounds, such as Aqualyx, that are designed to dissolve fat cells, which are then naturally eliminated by the body